Related Experiment Video
Updated: Jun 23, 2026

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Growth hormone resistance in severe heart failure resolves after cardiac transplantation
Lars H Lund1, Pamela Freda, Jill J Williams
1Department of Cardiology, Karolinska University Hospital, N305, Stockholm, Sweden. lars.lund@alumni.duke.edu
Aims:
Severe heart failure (HF) is associated with cachexia; this is often reversed post cardiac transplantation (HTx) with frequent development of obesity. Growth hormone (GH) resistance is common in HF and may contribute to cachexia. Whether GH resistance resolves post HTx is unknown. We aimed to confirm that HF is associated with GH resistance and to test the hypothesis that GH resistance resolves post HTx.
Methods And Results:
We measured GH, insulin-like growth factor-1 (IGF-1), and body composition in 10 HF patients awaiting HTx, in 18 patients 11 +/- 8 months post HTx, and seven controls. Body mass index was 23.5 +/- 3.2 in HF patients and 29.3 +/- 5.7 post HTx. HTx patients had gained 14 +/- 8 kg since HTx. GH was elevated in HF (control: 0.21 +/- 0.25; HF: 1.13 +/- 1.19; HTx: 0.11 +/- 0.13 ng/mL; P < 0.007), while IGF-1 was higher in HTx (control: 114 +/- 57; HF: 94 +/- 52; HTx: 190 +/- 106 ng/mL; P < 0.02). HTx had higher total body and abdominal fat %.
Conclusion:
GH resistance is present in severe HF and resolves post HTx. These findings should be confirmed through larger trials.
Related Concept Videos
Pathophysiology of Heart Failure
Cardiomyopathy V: Interprofessional Care
Heart Failure II: Pathophysiology
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure I: Introduction

